Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Name | miRBASE accession |
---|---|
hsa-let-7a-5p
|
MIMAT0000062 |
hsa-let-7b-5p
|
MIMAT0000063 |
hsa-let-7c-5p
|
MIMAT0000064 |
hsa-let-7d-5p
|
MIMAT0000065 |
hsa-let-7e-5p
|
MIMAT0000066 |
hsa-let-7f-5p
|
MIMAT0000067 |
hsa-let-7g-5p
|
MIMAT0000414 |
hsa-let-7i-5p
|
MIMAT0000415 |
hsa-miR-98-5p
|
MIMAT0000096 |
hsa-miR-4458
|
MIMAT0018980 |
hsa-miR-4500
|
MIMAT0019036 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_25102252 | 5.76 |
ENST00000261192.7
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic |
chr1_+_152486950 | 4.93 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
chr2_-_1748214 | 4.35 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr12_+_4382917 | 3.91 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr19_+_6531010 | 3.69 |
ENST00000245817.3
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9 |
chr1_-_9189229 | 3.59 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
chr9_+_131174024 | 3.54 |
ENST00000420034.1
ENST00000372842.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
chr12_+_66217911 | 3.54 |
ENST00000403681.2
|
HMGA2
|
high mobility group AT-hook 2 |
chrX_-_107681633 | 3.52 |
ENST00000394872.2
ENST00000334504.7 |
COL4A6
|
collagen, type IV, alpha 6 |
chr7_-_23510086 | 3.48 |
ENST00000258729.3
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr21_-_28217721 | 3.28 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
chr1_+_15736359 | 3.24 |
ENST00000375980.4
|
EFHD2
|
EF-hand domain family, member D2 |
chr5_+_156887027 | 3.23 |
ENST00000435489.2
ENST00000311946.7 |
NIPAL4
|
NIPA-like domain containing 4 |
chr2_-_190044480 | 2.88 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr15_+_39873268 | 2.86 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
chr20_-_5591626 | 2.83 |
ENST00000379019.4
|
GPCPD1
|
glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae) |
chr12_-_69326940 | 2.80 |
ENST00000549781.1
ENST00000548262.1 ENST00000551568.1 ENST00000548954.1 |
CPM
|
carboxypeptidase M |
chr12_-_85306594 | 2.77 |
ENST00000266682.5
|
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15 |
chr10_+_102106829 | 2.75 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
chr13_+_110959598 | 2.75 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr1_-_28503693 | 2.73 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chr7_+_100797678 | 2.61 |
ENST00000337619.5
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
chr12_+_1800179 | 2.48 |
ENST00000357103.4
|
ADIPOR2
|
adiponectin receptor 2 |
chr17_+_41476327 | 2.44 |
ENST00000320033.4
|
ARL4D
|
ADP-ribosylation factor-like 4D |
chr5_+_38846101 | 2.40 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr1_-_204121013 | 2.28 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
chr11_+_130318869 | 2.24 |
ENST00000299164.2
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
chr6_+_36646435 | 2.14 |
ENST00000244741.5
ENST00000405375.1 ENST00000373711.2 |
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
chr16_+_2479390 | 2.03 |
ENST00000397066.4
|
CCNF
|
cyclin F |
chr19_+_926000 | 1.92 |
ENST00000263620.3
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like) |
chr3_-_52090461 | 1.91 |
ENST00000296483.6
ENST00000495880.1 |
DUSP7
|
dual specificity phosphatase 7 |
chr8_-_29208183 | 1.90 |
ENST00000240100.2
|
DUSP4
|
dual specificity phosphatase 4 |
chr9_-_72287191 | 1.88 |
ENST00000265381.4
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1 |
chr20_-_46415297 | 1.85 |
ENST00000467815.1
ENST00000359930.4 |
SULF2
|
sulfatase 2 |
chr12_+_56915713 | 1.85 |
ENST00000262031.5
ENST00000552247.2 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr6_+_106546808 | 1.83 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr2_+_75061108 | 1.82 |
ENST00000290573.2
|
HK2
|
hexokinase 2 |
chr3_-_87040233 | 1.81 |
ENST00000398399.2
|
VGLL3
|
vestigial like 3 (Drosophila) |
chr1_+_203595903 | 1.77 |
ENST00000367218.3
ENST00000367219.3 ENST00000391954.2 |
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr20_+_6748311 | 1.75 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
chr1_+_38158090 | 1.72 |
ENST00000373055.1
ENST00000327331.2 |
CDCA8
|
cell division cycle associated 8 |
chr18_-_12657988 | 1.72 |
ENST00000410092.3
ENST00000409402.4 |
SPIRE1
|
spire-type actin nucleation factor 1 |
chr3_+_49209023 | 1.70 |
ENST00000332780.2
|
KLHDC8B
|
kelch domain containing 8B |
chr6_+_12290586 | 1.69 |
ENST00000379375.5
|
EDN1
|
endothelin 1 |
chr5_-_139726181 | 1.62 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr1_-_153363452 | 1.60 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr2_+_70142189 | 1.57 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
chr12_-_12674032 | 1.57 |
ENST00000298573.4
|
DUSP16
|
dual specificity phosphatase 16 |
chr3_-_185216766 | 1.56 |
ENST00000296254.3
|
TMEM41A
|
transmembrane protein 41A |
chr7_-_25019760 | 1.56 |
ENST00000352860.1
ENST00000353930.1 ENST00000431825.2 ENST00000313367.2 |
OSBPL3
|
oxysterol binding protein-like 3 |
chr13_-_30881621 | 1.55 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chrX_+_64887512 | 1.54 |
ENST00000360270.5
|
MSN
|
moesin |
chr2_+_10262442 | 1.54 |
ENST00000360566.2
|
RRM2
|
ribonucleotide reductase M2 |
chr19_+_531713 | 1.51 |
ENST00000215574.4
|
CDC34
|
cell division cycle 34 |
chr1_+_230202936 | 1.49 |
ENST00000366672.4
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
chr14_-_53162361 | 1.48 |
ENST00000395686.3
|
ERO1L
|
ERO1-like (S. cerevisiae) |
chr6_+_41606176 | 1.47 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
chr8_-_144623595 | 1.47 |
ENST00000262577.5
|
ZC3H3
|
zinc finger CCCH-type containing 3 |
chr13_-_33859819 | 1.46 |
ENST00000336934.5
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr15_-_45815005 | 1.46 |
ENST00000261867.4
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4 |
chr10_+_101419187 | 1.41 |
ENST00000370489.4
|
ENTPD7
|
ectonucleoside triphosphate diphosphohydrolase 7 |
chr14_-_35182994 | 1.41 |
ENST00000341223.3
|
CFL2
|
cofilin 2 (muscle) |
chr22_+_37447771 | 1.38 |
ENST00000402077.3
ENST00000403888.3 ENST00000456470.1 |
KCTD17
|
potassium channel tetramerization domain containing 17 |
chr15_+_74833518 | 1.37 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr3_-_16306432 | 1.36 |
ENST00000383775.4
ENST00000488423.1 |
DPH3
|
diphthamide biosynthesis 3 |
chr1_-_179198702 | 1.34 |
ENST00000502732.1
|
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr11_+_119076745 | 1.32 |
ENST00000264033.4
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase |
chr15_+_63481668 | 1.31 |
ENST00000321437.4
ENST00000559006.1 ENST00000448330.2 |
RAB8B
|
RAB8B, member RAS oncogene family |
chr17_-_48278983 | 1.30 |
ENST00000225964.5
|
COL1A1
|
collagen, type I, alpha 1 |
chr21_-_42880075 | 1.30 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
chr13_+_52158610 | 1.25 |
ENST00000298125.5
|
WDFY2
|
WD repeat and FYVE domain containing 2 |
chr14_+_24867992 | 1.24 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr5_-_64064508 | 1.23 |
ENST00000513458.4
|
SREK1IP1
|
SREK1-interacting protein 1 |
chr11_+_63580855 | 1.20 |
ENST00000294244.4
|
C11orf84
|
chromosome 11 open reading frame 84 |
chr6_+_34204642 | 1.18 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chr17_+_1958388 | 1.18 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
chr16_+_447209 | 1.17 |
ENST00000382940.4
ENST00000219479.2 |
NME4
|
NME/NM23 nucleoside diphosphate kinase 4 |
chr9_+_128509624 | 1.16 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr3_+_150126101 | 1.13 |
ENST00000361875.3
ENST00000361136.2 |
TSC22D2
|
TSC22 domain family, member 2 |
chr20_-_48532019 | 1.13 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
chr3_+_121774202 | 1.13 |
ENST00000469710.1
ENST00000493101.1 ENST00000330540.2 ENST00000264468.5 |
CD86
|
CD86 molecule |
chr6_+_11094266 | 1.13 |
ENST00000416247.2
|
SMIM13
|
small integral membrane protein 13 |
chr1_-_24126892 | 1.11 |
ENST00000374497.3
ENST00000425913.1 |
GALE
|
UDP-galactose-4-epimerase |
chr7_+_76090993 | 1.10 |
ENST00000425780.1
ENST00000456590.1 ENST00000451769.1 ENST00000324432.5 ENST00000307569.8 ENST00000457529.1 ENST00000446600.1 ENST00000413936.2 ENST00000423646.1 ENST00000438930.1 ENST00000430490.2 |
DTX2
|
deltex homolog 2 (Drosophila) |
chr1_-_120190396 | 1.08 |
ENST00000421812.2
|
ZNF697
|
zinc finger protein 697 |
chr2_+_74881355 | 1.06 |
ENST00000357877.2
|
SEMA4F
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F |
chr3_+_171758344 | 1.05 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
chr15_+_89164520 | 1.04 |
ENST00000332810.3
|
AEN
|
apoptosis enhancing nuclease |
chr9_-_77567743 | 1.03 |
ENST00000376854.5
|
C9orf40
|
chromosome 9 open reading frame 40 |
chr14_+_75469606 | 1.03 |
ENST00000266126.5
|
EIF2B2
|
eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa |
chr19_+_14063278 | 1.02 |
ENST00000254337.6
|
DCAF15
|
DDB1 and CUL4 associated factor 15 |
chr11_+_69455855 | 1.01 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr11_-_12030629 | 1.01 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr21_-_46131470 | 1.00 |
ENST00000323084.4
|
TSPEAR
|
thrombospondin-type laminin G domain and EAR repeats |
chr17_+_36508111 | 1.00 |
ENST00000331159.5
ENST00000577233.1 |
SOCS7
|
suppressor of cytokine signaling 7 |
chr3_-_48229846 | 0.99 |
ENST00000302506.3
ENST00000351231.3 ENST00000437972.1 |
CDC25A
|
cell division cycle 25A |
chr15_+_45879321 | 0.98 |
ENST00000220531.3
ENST00000567461.1 |
BLOC1S6
|
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
chr14_+_53019822 | 0.96 |
ENST00000321662.6
|
GPR137C
|
G protein-coupled receptor 137C |
chr19_+_34287751 | 0.96 |
ENST00000590771.1
ENST00000589786.1 ENST00000284006.6 ENST00000588881.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
chr5_-_131563501 | 0.96 |
ENST00000401867.1
ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chr7_-_106301405 | 0.95 |
ENST00000523505.1
|
CCDC71L
|
coiled-coil domain containing 71-like |
chr7_+_120628731 | 0.94 |
ENST00000310396.5
|
CPED1
|
cadherin-like and PC-esterase domain containing 1 |
chr8_+_126442563 | 0.93 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr17_-_42908155 | 0.93 |
ENST00000426548.1
ENST00000590758.1 ENST00000591424.1 |
GJC1
|
gap junction protein, gamma 1, 45kDa |
chr5_+_148206156 | 0.93 |
ENST00000305988.4
|
ADRB2
|
adrenoceptor beta 2, surface |
chr3_+_196594727 | 0.92 |
ENST00000445299.2
ENST00000323460.5 ENST00000419026.1 |
SENP5
|
SUMO1/sentrin specific peptidase 5 |
chr1_+_12227035 | 0.92 |
ENST00000376259.3
ENST00000536782.1 |
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B |
chr2_+_201676256 | 0.90 |
ENST00000452206.1
ENST00000410110.2 ENST00000409600.1 |
BZW1
|
basic leucine zipper and W2 domains 1 |
chr19_+_1450112 | 0.89 |
ENST00000590469.1
ENST00000233607.2 ENST00000238483.4 ENST00000590877.1 |
APC2
|
adenomatosis polyposis coli 2 |
chrX_-_54384425 | 0.89 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr10_+_125425871 | 0.89 |
ENST00000284674.1
|
GPR26
|
G protein-coupled receptor 26 |
chr1_-_229478236 | 0.88 |
ENST00000366687.1
ENST00000452552.1 |
CCSAP
|
centriole, cilia and spindle-associated protein |
chr15_+_90544532 | 0.88 |
ENST00000268154.4
|
ZNF710
|
zinc finger protein 710 |
chr15_-_51630772 | 0.88 |
ENST00000557858.1
ENST00000558328.1 ENST00000396404.4 ENST00000561075.1 ENST00000405011.2 ENST00000559980.1 ENST00000453807.2 ENST00000396402.1 |
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1 |
chr9_-_136242909 | 0.87 |
ENST00000371991.3
ENST00000545297.1 |
SURF4
|
surfeit 4 |
chr16_-_89007491 | 0.87 |
ENST00000327483.5
ENST00000564416.1 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr4_+_84457250 | 0.87 |
ENST00000395226.2
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr22_-_39640756 | 0.87 |
ENST00000331163.6
|
PDGFB
|
platelet-derived growth factor beta polypeptide |
chr2_-_230933709 | 0.86 |
ENST00000436869.1
ENST00000295190.4 |
SLC16A14
|
solute carrier family 16, member 14 |
chr9_+_118916082 | 0.85 |
ENST00000328252.3
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1 |
chr9_+_103189405 | 0.84 |
ENST00000395067.2
|
MSANTD3
|
Myb/SANT-like DNA-binding domain containing 3 |
chr9_+_77703414 | 0.84 |
ENST00000346234.6
|
OSTF1
|
osteoclast stimulating factor 1 |
chr7_+_138916231 | 0.83 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr19_+_45582453 | 0.83 |
ENST00000591607.1
ENST00000591747.1 ENST00000270257.4 ENST00000391951.2 ENST00000587566.1 |
GEMIN7
MARK4
|
gem (nuclear organelle) associated protein 7 MAP/microtubule affinity-regulating kinase 4 |
chr14_+_72399833 | 0.83 |
ENST00000553530.1
ENST00000556437.1 |
RGS6
|
regulator of G-protein signaling 6 |
chr6_+_46620676 | 0.83 |
ENST00000371347.5
ENST00000411689.2 |
SLC25A27
|
solute carrier family 25, member 27 |
chr14_+_100150622 | 0.83 |
ENST00000261835.3
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1 |
chr22_+_50609150 | 0.83 |
ENST00000159647.5
ENST00000395842.2 |
PANX2
|
pannexin 2 |
chr22_+_18043133 | 0.82 |
ENST00000327451.6
ENST00000399813.1 |
SLC25A18
|
solute carrier family 25 (glutamate carrier), member 18 |
chr6_+_125283566 | 0.82 |
ENST00000521654.2
|
RNF217
|
ring finger protein 217 |
chr3_-_122233723 | 0.82 |
ENST00000493510.1
ENST00000344337.6 ENST00000476916.1 ENST00000465882.1 |
KPNA1
|
karyopherin alpha 1 (importin alpha 5) |
chr3_+_102153859 | 0.82 |
ENST00000306176.1
ENST00000466937.1 |
ZPLD1
|
zona pellucida-like domain containing 1 |
chr17_+_18218587 | 0.81 |
ENST00000406438.3
|
SMCR8
|
Smith-Magenis syndrome chromosome region, candidate 8 |
chr1_+_100731749 | 0.81 |
ENST00000370128.4
ENST00000260563.4 |
RTCA
|
RNA 3'-terminal phosphate cyclase |
chr1_+_167599330 | 0.79 |
ENST00000367854.3
ENST00000361496.3 |
RCSD1
|
RCSD domain containing 1 |
chr19_-_51523275 | 0.79 |
ENST00000309958.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr2_+_113403434 | 0.78 |
ENST00000272542.3
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1 |
chr6_-_80657292 | 0.77 |
ENST00000369816.4
|
ELOVL4
|
ELOVL fatty acid elongase 4 |
chr2_+_113239710 | 0.77 |
ENST00000233336.6
|
TTL
|
tubulin tyrosine ligase |
chr20_-_32700075 | 0.77 |
ENST00000374980.2
|
EIF2S2
|
eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa |
chr14_+_32798547 | 0.77 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr8_-_48651648 | 0.77 |
ENST00000408965.3
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta |
chr9_-_35115836 | 0.77 |
ENST00000378566.1
ENST00000378554.2 ENST00000322813.5 |
FAM214B
|
family with sequence similarity 214, member B |
chr12_+_88536067 | 0.76 |
ENST00000549011.1
ENST00000266712.6 ENST00000551088.1 |
TMTC3
|
transmembrane and tetratricopeptide repeat containing 3 |
chr6_-_31107127 | 0.76 |
ENST00000259845.4
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2 |
chr19_-_47975417 | 0.75 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr7_-_92463210 | 0.75 |
ENST00000265734.4
|
CDK6
|
cyclin-dependent kinase 6 |
chr2_+_30454390 | 0.74 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr12_+_4918342 | 0.74 |
ENST00000280684.3
ENST00000433855.1 |
KCNA6
|
potassium voltage-gated channel, shaker-related subfamily, member 6 |
chr15_+_81293254 | 0.73 |
ENST00000267984.2
|
MESDC1
|
mesoderm development candidate 1 |
chrX_+_152907913 | 0.71 |
ENST00000370167.4
|
DUSP9
|
dual specificity phosphatase 9 |
chr1_+_204042723 | 0.71 |
ENST00000367204.1
|
SOX13
|
SRY (sex determining region Y)-box 13 |
chr19_+_38810447 | 0.71 |
ENST00000263372.3
|
KCNK6
|
potassium channel, subfamily K, member 6 |
chr5_+_150157444 | 0.71 |
ENST00000526627.1
|
SMIM3
|
small integral membrane protein 3 |
chr1_-_165325939 | 0.71 |
ENST00000342310.3
|
LMX1A
|
LIM homeobox transcription factor 1, alpha |
chr5_-_172198190 | 0.69 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr5_+_172261228 | 0.69 |
ENST00000393784.3
|
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
chr7_+_107220422 | 0.69 |
ENST00000005259.4
|
BCAP29
|
B-cell receptor-associated protein 29 |
chr9_-_73029540 | 0.69 |
ENST00000377126.2
|
KLF9
|
Kruppel-like factor 9 |
chrX_+_118108571 | 0.68 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
chr8_-_134584152 | 0.68 |
ENST00000521180.1
ENST00000517668.1 ENST00000319914.5 |
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr22_+_38093005 | 0.68 |
ENST00000406386.3
|
TRIOBP
|
TRIO and F-actin binding protein |
chr4_+_15004165 | 0.66 |
ENST00000538197.1
ENST00000541112.1 ENST00000442003.2 |
CPEB2
|
cytoplasmic polyadenylation element binding protein 2 |
chr1_+_154377669 | 0.66 |
ENST00000368485.3
ENST00000344086.4 |
IL6R
|
interleukin 6 receptor |
chr12_-_95611149 | 0.66 |
ENST00000549499.1
ENST00000343958.4 ENST00000546711.1 |
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chrX_+_16804544 | 0.65 |
ENST00000380122.5
ENST00000398155.4 |
TXLNG
|
taxilin gamma |
chr5_-_74326724 | 0.65 |
ENST00000322348.4
|
GCNT4
|
glucosaminyl (N-acetyl) transferase 4, core 2 |
chr19_-_14606900 | 0.65 |
ENST00000393029.3
ENST00000393028.1 ENST00000393033.4 ENST00000345425.2 ENST00000586027.1 ENST00000591349.1 ENST00000587210.1 |
GIPC1
|
GIPC PDZ domain containing family, member 1 |
chr2_+_234160217 | 0.65 |
ENST00000392017.4
ENST00000347464.5 ENST00000444735.1 ENST00000373525.5 ENST00000419681.1 |
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae) |
chr3_-_33138286 | 0.64 |
ENST00000416695.2
ENST00000342462.4 ENST00000399402.3 |
TMPPE
GLB1
|
transmembrane protein with metallophosphoesterase domain galactosidase, beta 1 |
chr8_+_24772455 | 0.64 |
ENST00000433454.2
|
NEFM
|
neurofilament, medium polypeptide |
chr3_-_57678772 | 0.63 |
ENST00000311128.5
|
DENND6A
|
DENN/MADD domain containing 6A |
chr5_+_150157860 | 0.63 |
ENST00000600109.1
|
AC010441.1
|
AC010441.1 |
chr8_-_124553437 | 0.63 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr14_+_75348592 | 0.63 |
ENST00000334220.4
|
DLST
|
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
chr6_-_32157947 | 0.62 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
chr11_-_78052923 | 0.62 |
ENST00000340149.2
|
GAB2
|
GRB2-associated binding protein 2 |
chr10_+_18948311 | 0.62 |
ENST00000377275.3
|
ARL5B
|
ADP-ribosylation factor-like 5B |
chr1_-_208417620 | 0.62 |
ENST00000367033.3
|
PLXNA2
|
plexin A2 |
chr3_-_185542817 | 0.61 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr15_-_23086394 | 0.61 |
ENST00000337435.4
|
NIPA1
|
non imprinted in Prader-Willi/Angelman syndrome 1 |
chr1_-_179846928 | 0.61 |
ENST00000367612.3
ENST00000609928.1 |
TOR1AIP2
|
torsin A interacting protein 2 |
chr14_+_55518349 | 0.60 |
ENST00000395468.4
|
MAPK1IP1L
|
mitogen-activated protein kinase 1 interacting protein 1-like |
chr9_+_116917807 | 0.60 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
chr2_+_121010324 | 0.60 |
ENST00000272519.5
|
RALB
|
v-ral simian leukemia viral oncogene homolog B |
chr22_-_36236265 | 0.59 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr15_+_83654950 | 0.59 |
ENST00000304191.3
|
FAM103A1
|
family with sequence similarity 103, member A1 |
chr3_+_49591881 | 0.59 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr8_+_70378852 | 0.59 |
ENST00000525061.1
ENST00000458141.2 ENST00000260128.4 |
SULF1
|
sulfatase 1 |
chr1_-_84972248 | 0.58 |
ENST00000370645.4
ENST00000370641.3 |
GNG5
|
guanine nucleotide binding protein (G protein), gamma 5 |
chr17_-_58469474 | 0.58 |
ENST00000300896.4
|
USP32
|
ubiquitin specific peptidase 32 |
chr2_+_153574428 | 0.58 |
ENST00000326446.5
|
ARL6IP6
|
ADP-ribosylation-like factor 6 interacting protein 6 |
chrX_-_15353629 | 0.57 |
ENST00000333590.4
ENST00000428964.1 ENST00000542278.1 |
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A |
chr6_+_4890226 | 0.57 |
ENST00000343762.5
|
CDYL
|
chromodomain protein, Y-like |
chrX_-_80065146 | 0.57 |
ENST00000373275.4
|
BRWD3
|
bromodomain and WD repeat domain containing 3 |
chr12_+_56862301 | 0.57 |
ENST00000338146.5
|
SPRYD4
|
SPRY domain containing 4 |
chr9_-_111696340 | 0.55 |
ENST00000374647.5
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein |
chr1_+_153232160 | 0.55 |
ENST00000368742.3
|
LOR
|
loricrin |
chr7_+_5229819 | 0.55 |
ENST00000288828.4
ENST00000401525.3 ENST00000404704.3 |
WIPI2
|
WD repeat domain, phosphoinositide interacting 2 |
chr3_-_101039402 | 0.55 |
ENST00000193391.7
|
IMPG2
|
interphotoreceptor matrix proteoglycan 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.0 | 5.8 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
1.0 | 2.9 | GO:0002605 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
0.9 | 4.7 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.9 | 3.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.9 | 2.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.9 | 2.7 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.6 | 2.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.6 | 1.8 | GO:0098736 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.6 | 1.7 | GO:0060129 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.6 | 1.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.5 | 1.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.4 | 2.1 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.4 | 1.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 2.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 2.0 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.4 | 0.4 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.4 | 1.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.4 | 3.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 1.8 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.3 | 0.9 | GO:0045659 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 0.9 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.3 | 1.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 0.9 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.3 | 2.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 2.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 1.8 | GO:1904925 | negative regulation of mitochondrial membrane permeability(GO:0035795) positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.3 | 1.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 3.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 3.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 1.0 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.2 | 1.7 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 1.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 3.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 3.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.9 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.2 | 0.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.4 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 0.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.2 | 2.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.2 | 0.9 | GO:1905176 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.2 | 0.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 1.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.2 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 1.4 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.2 | 0.6 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.2 | 0.2 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.2 | 1.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 3.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.5 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.2 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 2.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.2 | 0.5 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 0.6 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.2 | 0.5 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) negative regulation of membrane invagination(GO:1905154) |
0.1 | 1.2 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 2.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.7 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 1.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.4 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.9 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 1.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 1.4 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.1 | 4.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.8 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 2.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.1 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 1.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.8 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 0.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 0.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.7 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.5 | GO:0090245 | somatic muscle development(GO:0007525) axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 1.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 2.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.2 | GO:1903061 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) positive regulation of protein lipidation(GO:1903061) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.8 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.8 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.1 | 0.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.4 | GO:1904075 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 1.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.1 | 0.2 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.1 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 1.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.4 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
0.1 | 0.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 1.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 2.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.8 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 0.1 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 0.6 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 1.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.4 | GO:1902715 | secretory granule localization(GO:0032252) positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:0009644 | response to high light intensity(GO:0009644) cellular response to light intensity(GO:0071484) |
0.1 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.4 | GO:0032535 | regulation of cellular component size(GO:0032535) |
0.1 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.5 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.5 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.0 | 3.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 2.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.6 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.3 | GO:0034770 | regulation of histone H3-K36 methylation(GO:0000414) histone H4-K20 methylation(GO:0034770) |
0.0 | 0.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.0 | 0.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 0.1 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.0 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.0 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 1.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.3 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.0 | 0.4 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 1.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 1.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0034184 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 1.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 1.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 2.8 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 2.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 1.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.1 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
0.0 | 0.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.3 | GO:0016050 | vesicle organization(GO:0016050) |
0.0 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 1.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.0 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0030397 | mitotic nuclear envelope disassembly(GO:0007077) membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 1.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 1.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.6 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 1.9 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 1.1 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.4 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.3 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.0 | GO:0021502 | neural fold elevation formation(GO:0021502) negative regulation of mononuclear cell migration(GO:0071676) allantois development(GO:1905069) |
0.0 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 6.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.8 | 2.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.7 | 2.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.7 | 3.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.4 | 1.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 4.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 2.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 1.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 2.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 1.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 2.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.9 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.2 | 0.4 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.2 | 0.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.5 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.9 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 1.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.5 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.3 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.3 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 1.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.0 | 0.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.0 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.8 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 4.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 1.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 1.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 3.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.0 | 2.0 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.7 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 2.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 2.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 1.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 2.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.8 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 5.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 2.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 4.4 | GO:0045121 | membrane raft(GO:0045121) |
0.0 | 0.3 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.8 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
1.0 | 2.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 2.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.9 | 2.8 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.9 | 3.5 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.9 | 4.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.9 | 2.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 2.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.6 | 1.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.6 | 2.8 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.5 | 2.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.5 | 2.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 0.7 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.3 | 1.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 4.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 1.1 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.3 | 0.8 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.3 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.2 | 0.9 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.2 | 2.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 1.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 1.8 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.8 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.2 | 0.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 1.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 3.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 3.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.2 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.6 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 1.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.4 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 1.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 2.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 4.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 11.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 1.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 4.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.9 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.2 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 3.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 |